Explore the latest in heart failure, including recent guidelines and advances in treatment of HF with reduced and preserved ejection fraction.
This study evaluates whether low plasma transthyretin concentration is associated with incident heart failure in the general population.
This cohort study evaluates the association of heart failure and ischemic heart disease with diabetes complications.
This Viewpoint proposes that a polypill combination of a β-blocker, renin angiotensin inhibitor, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter 2 inhibitor might be the most efficient way to deliver guideline-directed HFrEF therapy, and proposes a research roadmap to design and evaluate the pill and implementation strategies for getting it to patients.
This case report describes a patient with severe biventricular dilatation and functional mitral and tricuspid regurgitation.
This unblinded cluster randomized trial compares the effects of an emergency department (ED)–based comprehensive, guideline-recommended care bundle vs usual care on the number of days alive and out of the hospital at 30 days in older patients with acute heart failure cared for at French hospitals.
This secondary analysis the Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction clinical trial evaluates clinical characteristics, outcomes, and treatment response to vericiguat according to prespecified index event subgroups and time from index heart failure hospitalization.
This cohort study evaluates candidacy for initiation of dapagliflozin based on the US Food and Drug Administration label among contemporary US patients with heart failure with reduced ejection fraction and describes potential barriers to therapeutic optimizations.
This cohort study examines the trends, patient characteristics, and outcomes associated with noncardiac surgery among patients with left ventricular assist devices (LVADs).
This cross-sectional study assesses the concordance between Pooled Cohort Equations to Prevent Heart Failure risk scoring and the presence of subclinical cardiac maladaptation in the community.
This cross-sectional study assesses survival outcomes among patients on the heart transplant waiting list during the past 3 decades and examines the association of ventricular assist devices and the 2006 United Network for Organ Sharing allocation policy with survival.
This economic evaluation assesses the cost-effectiveness of inpatient initiation of sacubitril-valsartan vs enalapril compared with no initiation or posthospitalization initiation of sacubitril-valsartan in patients who have heart failure with reduced ejection fraction.
This cohort study assesses home time after hospitalization for heart failure through Medicare administrative claims data and its association with 30-day risk-standardized readmission rates and risk-standardized mortality rates.
This national cohort study evaluates trends in heart failure incidence across risk factor strata, including hypertension, diabetes, obesity, acute myocardial infarction, and atrial fibrillation among Medicare beneficiaries.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: